The article discusses the U.S. Food and Drug Administration's (FDA) final rule covering the substances generally recognized as safe (GRAS). Topics discussed include a brief history of the FDA rulemaking process to GRAS ingredients and the FDA's rationale for its decision to adopt a voluntary notification process.